
    
      This study was an open-label, three period, fixed sequence study in healthy male and female
      subjects performed at a single study center.

      The study comprised:

        -  Screening during Days -28 to -2 (both inclusive).

        -  Three treatment periods separated by a washout period of at least 10 days.
    
  